| DB00002 |
yes |
antagonist |
Cetuximab |
approved |
DB00072 |
unknown |
NA |
Trastuzumab |
approved|investigational |
DB00281 |
unknown |
antagonist |
Lidocaine |
approved|vet_approved |
DB00317 |
yes |
antagonist |
Gefitinib |
approved|investigational |
DB00530 |
yes |
antagonist |
Erlotinib |
approved|investigational |
DB01259 |
yes |
antagonist |
Lapatinib |
approved|investigational |
DB01269 |
yes |
suppressor |
Panitumumab |
approved|investigational |
DB03496 |
unknown |
NA |
Alvocidib |
experimental|investigational |
DB04988 |
unknown |
NA |
IGN311 |
investigational |
DB05101 |
unknown |
NA |
Matuzumab |
investigational |
DB05294 |
unknown |
inhibitor |
Vandetanib |
approved |
DB05374 |
unknown |
NA |
Rindopepimut |
investigational |
DB05424 |
unknown |
NA |
Canertinib |
investigational |
DB05944 |
unknown |
NA |
Varlitinib |
investigational |
DB07602 |
unknown |
NA |
S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE |
experimental |
DB07662 |
unknown |
NA |
N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE |
experimental |
DB08916 |
yes |
inhibitor |
Afatinib |
approved |
DB09330 |
yes |
inhibitor |
Osimertinib |
approved |
DB09559 |
yes |
antagonist |
Necitumumab |
approved |
DB11731 |
no |
antibody |
Depatuxizumab mafodotin |
investigational |
DB11737 |
unknown |
antagonist |
Icotinib |
approved|investigational |
DB12202 |
yes |
antagonist |
Zalutumumab |
investigational |
DB13164 |
yes |
inhibitor |
Olmutinib |
approved |